Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of hub ferroptosis-related genes and the immune landscape in recurrent pregnancy loss and unexplained infertility using bioinformatics analysis. | Ann Transl Med | 2023 | 37007565 | PubTator, text mining | PubMed |
| The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target. | Front Immunol | 2023 | 36993955 | PubTator, text mining | PubMed |
| Endocrine Disruptor Compounds in Environment: Focus on Women's Reproductive Health and Endometriosis. | Int J Mol Sci | 2023 | 36982755 | PubTator, text mining | PubMed |
| Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients. | Cancers (Basel) | 2023 | 36980682 | PubTator, text mining | PubMed |
| Computational and Functional Analysis of Structural Features in the ZAKα Kinase. | Cells | 2023 | 36980309 | PubTator, text mining | PubMed |
| Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer. | Cells | 2023 | 36980267 | PubTator, text mining | PubMed |
| HERVs and Cancer-A Comprehensive Review of the Relationship of Human Endogenous Retroviruses and Human Cancers. | Biomedicines | 2023 | 36979914 | PubTator, text mining | PubMed |
| Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis. | Front Oncol | 2023 | 36969076 | PubTator, text mining | PubMed |
| Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer's Disease. | ACS Cent Sci | 2023 | 36968534 | PubTator, text mining | PubMed |
| Immunoregulatory actions of calf thymus extract (TFX®) in vitro in relation to its effect on expression of mitogen activated protein kinases. | Int Immunopharmacol | 2023 | 36963263 | PubTator, text mining | PubMed |
| A network map of cytoskeleton-associated protein 4 (CKAP4) mediated signaling pathway in cancer. | J Cell Commun Signal | 2023 | 36944905 | PubTator, text mining | PubMed |
| Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective. | Autophagy Rep | 2023 | 36936397 | PubTator, text mining | PubMed |
| Decrypting drug actions and protein modifications by dose- and time-resolved proteomics. | Science | 2023 | 36926954 | PubTator, text mining | PubMed |
| Comprehensive characterization of B7 family members in NSCLC and identification of its regulatory network. | Sci Rep | 2023 | 36922519 | PubTator, text mining | PubMed |
| Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. | Oncol Lett | 2023 | 36909377 | PubTator, text mining | PubMed |
| Beyond the Clinic: The Activation of Diverse Cellular and Humoral Factors Shapes the Immunological Status of Patients with Active Tuberculosis. | Int J Mol Sci | 2023 | 36902461 | PubTator, text mining | PubMed |
| Combined computational analysis and cytology show limited depth osteogenic effect on bone defects in negative pressure wound therapy. | Front Bioeng Biotechnol | 2023 | 36873351 | PubTator, text mining | PubMed |
| Lung Remodeling Regions in Long-Term Coronavirus Disease 2019 Feature Basal Epithelial Cell Reprogramming. | Am J Pathol | 2023 | 36868468 | PubTator, text mining | PubMed |
| 3PNMF-MKL: A non-negative matrix factorization-based multiple kernel learning method for multi-modal data integration and its application to gene signature detection. | Front Genet | 2023 | 36865387 | PubTator, text mining | PubMed |
| MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease. | Clin Kidney J | 2023 | 36865016 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers?page=11